We are delighted to announce that Experimental Hematology & Oncology has been accepted for inclusion in Science Citation Index Expanded (SCIE), a key database of Web of Science, published by Clarivate Analytics. Starting 2020, Experimental Hematology & Oncology will be published in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score, and Journal Impact Factor.
Experimental Hematology & Oncology accepted for inclusion in SCIE
Aims and scope
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Kongming Wu, Tongji Medical College
Delong Liu, New York Medical College
Zihai Li, Medical University of South Carolina
Editor's quote (Dr. Delong Liu)
"Like our companion journal, Journal of Hematology & Oncology, Experimental Hematology & Oncology publishes on all aspects of hematology and oncology, which are closely intertwined and rapidly evolving fields. It also emphasizes basic and translational research, as well as patient-oriented research and clinical trials with ‘negative’ or preliminary results. The journal is an international platform for sharing findings in these areas and adheres to fast turnaround times."
Annual Journal Metrics
40 days to first decision for reviewed manuscripts only
28 days to first decision for all manuscripts
73 days from submission to acceptance
9 days from acceptance to publication
108 Altmetric Mentions
On the blog
30 September 2019
09 September 2019
06 September 2019